In Focus
Editorials
- Interruption of natalizumab therapy for multiple sclerosisWhat are the risks?Robert T. Naismith, Dennis Bourdette
- Lacunes and cognitive declineLittle things matterChristopher M. Filley, Amy Brodtmann
Articles
- Disease activity return during natalizumab treatment interruption in patients with multiple sclerosisP.W. O'Connor, A. Goodman, L. Kappos, F.D. Lublin, D.H. Miller, C. Polman, R.A. Rudick, W. Aschenbach, N. Lucas
- Stress and the risk of multiple sclerosisT. Riise, D.C. Mohr, K.L. Munger, J.W. Rich-Edwards, I. Kawachi, A. Ascherio
- Incident lacunes influence cognitive declineThe LADIS studyH. Jokinen, A.A. Gouw, S. Madureira, R. Ylikoski, E.C.W. van Straaten, W.M. van der Flier, F. Barkhof, P. Scheltens, F. Fazekas, R. Schmidt, A. Verdelho, J.M. Ferro, L. Pantoni, D. Inzitari, T. Erkinjuntti
- Vascular risk factors and longitudinal changes on brain MRIThe ARIC studyD.S. Knopman, A.D. Penman, D.J. Catellier, L.H. Coker, D.K. Shibata, A.R. Sharrett, T.H. Mosley
- Predicting survival in frontotemporal dementia with motor neuron diseaseE.A. Coon, E.J. Sorenson, J.L. Whitwell, D.S. Knopman, K.A. Josephs
- Real-life driving outcomes in Parkinson diseaseE.Y. Uc, M. Rizzo, A.M. Johnson, J.L. Emerson, D. Liu, E.D. Mills, S.W. Anderson, J.D. Dawson
- Sensory neuropathy as part of the cerebellar ataxia neuropathy vestibular areflexia syndromeD.J. Szmulewicz, J.A. Waterston, G.M. Halmagyi, S. Mossman, A.M. Chancellor, C.A. McLean, E. Storey
- Clinical and MRI characteristics of acute migrainous infarctionM.E. Wolf, K. Szabo, M. Griebe, A. Förster, A. Gass, M.G. Hennerici, R. Kern
- Potential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastomaR.J. Young, A. Gupta, A.D. Shah, J.J. Graber, Z. Zhang, W. Shi, A.I. Holodny, A.M.P. Omuro
- Prognostic importance of serial postoperative EEGs after anterior temporal lobectomyChaturbhuj Rathore, Sankara P. Sarma, Kurupath Radhakrishnan
Views and Reviews
- Abbreviated report of the NIH/NINDS workshop on sudden unexpected death in epilepsyL.J. Hirsch, E.J. Donner, E.L. So, M. Jacobs, L. Nashef, J.L. Noebels, J.R. Buchhalter
Clinical/Scientific Notes
- Diabetes insipidus as a first manifestation in multiple sclerosisE. Thouvenot, C. Schmidt, C. Héroum, B. Carlander, A. Bonafé, W. Camu
- JC virus granule cell neuronopathy and hyper-IgE in HIV diseaseTiesong Shang, Ana Delgado, David Adams
Neuroimages
- Giant thoracic meningocele associated with neurofibromatosis 1Brian P. Walcott, Kristopher T. Kahle, John C. Wain, Lawrence F. Borges
Historical Abstracts
- Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MSR.A. Rudick, E. Fisher, J.-C. Lee, J. Simon, L. Jacobs, and the Multiple Sclerosis Collaborative Research Group
Resident and Fellow Section
- Clinical Reasoning: A young adult presents with focal weakness and hemorrhagic brain lesionsTuhin Virmani, Ashima Agarwal, Eric C. Klawiter
- Teaching NeuroImages: Unilateral prosopometamorphopsia as a dominant hemisphere-specific disconnection signJ.-Y. Cho, S.Y. Moon, K.-S. Hong, Y.-J. Cho, S.-C. Kim, S.-I. Hwang, S.-Y. Seo, J.-E. Kim, H.K. Park
Patient Page
- The influence of lacunes on cognitive functionRaghav Tripathi, Kevin Wang, Priyanka Mysore, David C. Spencer
Correspondence
- The MoCA: Well-suited screen for cognitive impairment in Parkinson diseaseJohan Marinus, J.C. Dalrymple-Alford, Dagmar Verbaan, Jacobus J. van Hilten, C.T. Nakas, M.R. MacAskill, L. Livingston, T.J. Anderson